1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires Diane Rinnovatore to Expand Structured Products Origination

Our Firm

December 22, 2015

Guggenheim Securities Hires Diane Rinnovatore to Expand Structured Products Origination

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Diane Rinnovatore will join the firm in January as a Senior Managing Director in the Investment Banking Division’s Structured Products Origination business.

“We are pleased to welcome Diane to Guggenheim," said Mark Van Lith, Co-CEO of Guggenheim Securities. “Guggenheim has established itself as a leader in Structured Products, bringing to market several of the largest and most significant transactions this year and leading the league tables in Non-Traditional / Esoteric ABS.1 We are excited to grow our Structured Products Origination capabilities by adding Diane’s wide-ranging experience advising structured products clients.”

Cory Wishengrad, Head of Structured Products Origination, added, “Diane is an experienced, trusted and well-respected banker in the securitization space. Diane’s deep experience in Consumer ABS and debt capital markets, as well as her strong client relationships with banks, finance companies, marketplace lenders and other market participants, will complement our market-leading Non-Traditional / Esoteric ABS platform. After working together for almost 15 years at Lehman and Barclays, it will be a privilege to have Diane on the team again.”

Ms. Rinnovatore joins Guggenheim Securities from Star Mountain Capital, where she served as Managing Director. Prior to Star Mountain, Diane served as Managing Director and Co-Head of Securitized Products Origination, Americas, at Barclays. She also served as Head of U.S. Bank Debt Capital Markets at Barclays and as Head of Consumer ABS at Lehman Brothers.

Ms. Rinnovatore earned her Bachelor of Arts in Business Administration from Moravian College and Master of Business Administration from Hofstra University.

1. Source: Asset Backed Alert, as of December 1, 2015.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $240 billion* in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by following us on Twitter at twitter.com/guggenheimptnrs.

*Assets under management are as of 9.30.2015 and include consulting services for clients whose assets are valued at approximately $48 billion.


Media Contact

Anthony Lacavaro
Guggenheim Partners
212.908.5098 office
Anthony.Lacavaro@GuggenheimPartners.com



November 09, 2020

Guggenheim Securities Hires David Levin to Expand Equity Capital Markets

NEW YORK, NY –  Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.

Read More

October 22, 2020

Guggenheim Securities Hires Joe Niemiec to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.

Read More

October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.